Moreover, viral vectors containing expressible CIITA, alone or in association with oncolytic viruses, or agents that can overcome the blood–brain barrier, could be used to target established GBM tumors and make them more immunogenic in order to trigger and/or increase the stimulation of tumor-specific Th cells (50). Here, CIITA is linked to glioblastoma.